AMAG Pharmaceuticals Short ratio
What is the Short ratio of AMAG Pharmaceuticals?
The Short ratio of AMAG Pharmaceuticals, Inc. is 1.83
What is the definition of Short ratio?
Short ratio is the number of shares sold short divided by the average daily volume.
= short interest / average daily volume
Short ratio is calculated by dividing the number of shares sold short by the average daily trading volume, generally over the last 30 trading days. The ratio represents the number of days it takes short sellers on average to repurchase all the borrowed shares. The ratio is used by both fundamental and technical traders to identify trends.
The percentage represents the number of days it takes short sellers on average to repurchase all the borrowed shares. Short selling is the practice of selling securities or other financial instruments that are not currently owned, and subsequently repurchasing them. In the event of an interim price decline, the short seller profits, since the cost of (re)purchase is less than the proceeds received upon the initial (short) sale. Conversely, the short position closes out at a loss if the price of a shorted instrument rises prior to repurchase. A high short ratio can be an indicator that there will be some buying pressure on the security that would increase its price.
Short ratio of companies in the Health Care sector on NASDAQ compared to AMAG Pharmaceuticals
What does AMAG Pharmaceuticals do?
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.
Companies with short ratio similar to AMAG Pharmaceuticals
- CDK Global Inc has Short ratio of 1.82
- Altria has Short ratio of 1.82
- Brasilagro Companhia Brasileira De Propriedade Agricola has Short ratio of 1.82
- BlackRock TCP Capital Corp has Short ratio of 1.82
- TORM plc has Short ratio of 1.82
- H&R Real Estate Investment Trust has Short ratio of 1.82
- AMAG Pharmaceuticals has Short ratio of 1.83
- Elysee Development has Short ratio of 1.84
- In8 Bio has Short ratio of 1.84
- Graybug Vision has Short ratio of 1.84
- Western Asset Investment Grade Income Fund Inc has Short ratio of 1.84
- Fortinet Inc has Short ratio of 1.84
- National has Short ratio of 1.84